We use Danish diabetes registry and health insurance data to analyze the extent, consequences, and determinants of under-use and overuse of oral anti-diabetic drugs. Less than half of patients consume the appropriate amount of medication--between 90% and 110% of the amount prescribed by their...

Understanding socioeconomic inequalities in health care is critical for achieving health equity. The aim of this paper is threefold: 1) to quantify inequality in diabetes health care service utilization; 2) to understand determinants of these inequalities in relation to socio-demographic and...

Pharmaceutical innovation appears to have reduced medication under-use and overuse: patients using newer drugs are significantly more likely to consume the appropriate amount, controlling for socioeconomic factors, average number of pills and average daily out-of-pocket costs

Novo Nordisk is one of the few highly reputed pharma businesses and there is a reason for it. Rather than stick to its economistic origins that so many of its competitors live and organize by, Novo Nordisk allowed itself to experiment and react to stakeholder criticism. Rather than reactively...

В статье рассматриваются методы проведения фармакоэкономического анализа в процессе формирования политики управления запасами лекарственных средств...